Befutur Biotechnologies Sa

Description

Founded in 1998, BeFutur Biotechnologies is a privately-held Swiss biotech company with a very specialized R&D team. BeFutur is on the forefront of research for harvesting adult autologous stem cells. It is the only company in the world that uses a totally animal serum free medium, thereby avoiding any risk of rejection and contamination. Its unique technology is based on a stable cell-culture method, which harvests cells usable in future cell therapies. Its research activities remain in stem cell differentiation to tissue engineering, with a primary focus on tissue regeneration.

Founded in 1994, Artificial Life, Inc. (OTC Bulletin Board: ALIF) develops, markets, and supports intelligent award winning and patent pending software robots and is a leading provider of data- and knowledge mining algorithms and biotech solutions. The company offers a variety of unique product suites for a wide variety of Internet based applications such as self-help, self-service, consultative selling, e-CRM, e-Finance and Mobile Computing.

NEW YORK, GENEVA, and MONTREAL, Oct. 15 /PRNewswire/ -- New York based Artificial Life Inc. (OTC Bulletin Board: ALIF), a leading provider of award winning intelligent software robot (bot) technology and specialist for computational biotech applications, announced today that it has entered into a partnership agreement with the Swiss/Canadian privately held biotech company BeFutur Biotechnologies SA, a technology leader in stem cell research and regenerative medicine.

Products & services

Similar companies nearby